<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>5</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>05</Month><Day>18</Day></PubDate></Journal><title locale="en_US">Gestational Diabetes and Risk of Developing Postpartum Type 2 Diabetes: How to Improve Follow‑up?</title><FirstPage>2038</FirstPage><LastPage>2038</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Endocrinology, Diabetology and Nutrition, University Hospital of Fez, Fez</affiliation></Author><Author><affiliation locale="en_US">Department of Endocrinology, Diabetology and Nutrition, University Hospital of Fez, Fez</affiliation></Author><Author><affiliation locale="en_US">Department of Biophysics and Clinical MRI Methods, Faculty of Medicine and Pharmacy, University of Fez, Fez</affiliation></Author><Author><affiliation locale="en_US">Department of Endocrinology, Diabetology and Nutrition, University Hospital of Agadir, Agadir</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>05</Month><Day>18</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Background&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Gestational diabetes mellitus (GDM) is defned by World Health Organization as glucose intolerance diagnosed for the frst time during pregnancy; GDM affects 7% of pregnancies. Women with earlier GDM have higher risk to develop type 2 diabetes (T2D). The aim of our study was to evaluate the outcomes of GDM and to assess the impact of recalling patients in the postpartum stage by phone, the target was to assess T2D or impaired glucose tolerance in women&lt;br /&gt;with a history of GDM. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Methods&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;This prospective study included 200 patients with GDM that have&lt;br /&gt;received education sessions regarding the major interest of screen T2D using 75 g of oral glucose tolerance testing in the 3&lt;/span&gt;&lt;span class="fontstyle2" style="font-size: 5pt;"&gt;rd &lt;/span&gt;&lt;span class="fontstyle2"&gt;month after birth.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Results&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Only 22.5% (&lt;/span&gt;&lt;span class="fontstyle3"&gt;n &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 45) women spontaneously complied to assess T2D. About 15% have had developed T2D and 28% prediabetes. Risk factors of&lt;br /&gt;T2D onset were younger gestational age at the occurrence GD, higher fasting blood glucose, and frequent use of insulin. &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0"&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Women with GD history demonstrated high risk of developing&lt;br /&gt;T2D. Simple changes of lifestyle were shown to be an effcient prevention protocol. Despite therapeutical education, few women spontaneously complied with T2D screening. The telephone reminders could improve the screening observance therefore patient’s outcome.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle0" style="color: #00652e;"&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle3"&gt;Diabetes mellitus, follow‑up, gestational diabetes&lt;/span&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/2038</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/2038/717717857</pdf_url></Article></Articles>
